Department of Health and Social Care written question – answered on 28th September 2022.
To ask the Secretary of State for Health and Social Care, with reference to the announcement on 12 August 2022 that Government will not be procuring any doses of Evusheld at this time, if he will set out in detail the decision making process including (a) what discussions were held by those responsible for making that decision, (b) what evidence informed that decision and (c) the rationale for that decision, in the four weeks before that procurement decision was taken.
The decision not to procure Evusheld at this present time for prevention through emergency routes is based on independent clinical advice by the multi-agency RAPID C-19 and a national expert policy working group. These groups considered a range of evidence, including clinical trial data, in vitro analysis and emerging observational studies. RAPID C-19 monitors activity in clinical trials for emerging evidence and where treatments are proven to be clinically effective, enables access for National Health Service patients. The Chief Medical Officer for England is content that the correct process for providing clinical advice has been followed and it should now be referred to the National Institute for Health and Care Excellence for further evaluation. The Department intends to publish further details of the clinical advice received shortly.
Yes0 people think so
No8 people think not
Would you like to ask a question like this yourself? Use our Freedom of Information site.